arginine vasopressin has been researched along with alfentanil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fyhrquist, F; Heinonen, J; Hynynen, M; Lehtinen, AM; Salmenperä, M; Takkunen, O | 1 |
1 review(s) available for arginine vasopressin and alfentanil
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for arginine vasopressin and alfentanil
| Article | Year |
|---|---|
Continuous infusion of fentanyl or alfentanil for coronary artery surgery. Effects on plasma cortisol concentration, beta-endorphin immunoreactivity and arginine vasopressin.
Topics: Adult; Alfentanil; Anesthesia, Intravenous; Anesthetics; Arginine Vasopressin; beta-Endorphin; Coronary Artery Bypass; Endorphins; Female; Fentanyl; Hormones; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged | 1986 |
1 other study(ies) available for arginine vasopressin and alfentanil
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |